|

Adjuvant transarterial chemoembolization Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Guangxi Medical University1

Indications

  • Liver Disease1
  • Transarterial Chemoembolization1
  • Adjuvant1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other1 trial

Adjuvant TACE in HCC With High-risk Recurrence Factors
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.